KP-413
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KP-413, covering 2012-04-06 to 2012-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD) [Phase 1, Phase 2]